New Materials

The development of Fujian's new materials industry is accelerating, with increasing industrial clustering effects, gradual improvement of the innovation system, and continuous enrichment of new material varieties. A group of leading backbone enterprises has been cultivated, including CATL, San'an Optoelectronics, Wanhua Chemical (Fujian), Xiamen Tungsten, Fuyao Glass, Tsingshan Group, Zijin Mining Group, Highsun Group, and Eversun Group. Leveraging the driving role of these leading enterprises, Fujian has established a number of distinctive new materials clusters with certain influence domestically and internationally, focusing on optoelectronic information materials, advanced chemical materials, new energy materials, advanced non-ferrous metal materials, rare earth new materials, stainless steel, and advanced textile functional materials. 4 industrial clusters have been selected as national-level characteristic clusters for small and medium-sized enterprises: the Fuzhou Changle Textile New Materials Cluster, the Shaowu Fluorine New Materials Cluster, the Jinjiang Sports Shoes Raw and Auxiliary Materials Cluster, and the Wuping Display Module and Material Manufacturing Cluster. The Ningde Wanwu Stainless Steel Industrial Park has been recognized as a national-level new industrialization demonstration base.

Biomedicine

In 2025, Fujian Province had 341 above-designated-size pharmaceutical enterprises, achieving an operating revenue of RMB 50.28 billion. The province's pharmaceutical industry has cultivated a relatively comprehensive industrial system covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) prepared prescriptions, TCM decoction pieces, and medical devices. During the "14th Five-Year Plan" period, 4 Category-1 innovative drugs and 4 Category-2 innovative drugs were approved, accelerating industrial innovation. Maxim Biotech and Double Medical were promoted as leaders in the industrial chain. 6 projects from 3 enterprises, including Double Medical, were shortlisted for the Ministry of Industry and Information Technology's List of “Open Bidding for Selecting the Best Candidates for Innovation Tasks in Biomedical Materials.” 11 provincial-level industrial leading enterprises in biomedicine, such as Zhangzhou Pien Tze Huang Pharmaceuticals, and 17 enterprises under cultivation for leading status were fostered. 3 enterprises, including AmoyDx, were recognized as national single-item champions (in specific products); 25 enterprises, including Fukang Pharmaceuticals, were recognized as provincial single-item champions (in specific products). 19 pharmaceutical enterprises, including Southern Pharmaceuticals and Fukang Pharmaceuticals, were recognized as National "Little Giants" Enterprises Using Specialized and Advanced Technologies to Create Innovative and Unique Products. 15 enterprises, including Double Medical, Cosunter Pharmaceutical, and Haixi Pharmaceuticals, are listed companies.